Pegfilgrastim biosimilar (Siam Bioscience)

培非司亭生物类似药 (Siam Bioscience)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Siam Bioscience)

Drug Alias Name非格司亭生物仿制药 (Siam Bioscience)培非司亭生物仿制药 (Siam Bioscience)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSiam Bioscience

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSiam Bioscience

Active IndicationsN/A

Inactive IndicationsNeutropenia

ATC CodeL03AA13